Direct message the job poster from Innovent Biologics
盛权莉
招聘高级经理
Job Responsibilities:
This role will be responsible for the timely and efficient development and submission of manuscripts, abstracts, and meeting presentations.
Key Responsibilities:
Lead and manage the execution of publication tactics (e.g., manuscripts, abstracts, posters, oral presentations) across the product portfolio consistent with SOP
Implement appropriate publication strategy and provide ideas for generating publications to fill clinical, economic, health outcomes, quality of life and scientific knowledge gaps
Facilitate strategic discussions/decisions related to publication planning and execution
Serve as the Publication subject matter expert for the Therapeutic Area product(s) and maintain expertise in TA/Product scientific data, industry-related information, and evolution of disease state
Support the development of scientific communications strategy and planning for oncology assets
Contribute to the development of scientific content for congress medical communication activities.
Develop expertise in disease area of focus through continuous surveillance of the medical and scientific literature for relevant publications, and lead development of monthly literature updates.
Requirements:
MS, or PhD in a Life Science or a PharmD required
At least 4 years’ publication & scientific affairs experience in Pharma.
Proficiency in scientific literature searches, analysis, and evaluation.
Understanding of industry regulations and guidelines governing publications and medical communications (eg, FDA, OIG, GPP3, ICJME).
Excellent interpersonal skills with the ability to work collaboratively in teams and with autonomy as necessary
Strong planning and organizational skills to prioritize projects in a dynamic, fast-paced environment.
Good interpersonal and ownership.
Hybrid Working.
Seniority level
Mid-Senior level
Employment type
Full-time
Job function
Health Care Provider
Industries
Pharmaceutical Manufacturing
Referrals increase your chances of interviewing at Innovent Biologics by 2x